Breaking

Thursday, August 20, 2026

Tailored cancer drug curbs melanoma recurrence in trial

Employees train to be cell therapy specialists at Gilead unit Kite's manufacturing facility in Frederick Maryland, US, March 14, 2024. — Reuters

US drugmakers Merck and Moderna said on Wednesday an experimental melanoma drug that delivers treatment tailored to a patient's...

from Health - Geo News https://ift.tt/nTp3W1E